4D Molecular Therapeutics (FDMT) Net Margin Growth (1y) (2021 - 2026)
4D Molecular Therapeutics (FDMT) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.25 Mn |
| Mar 31, 2026 | 34.04 Mn |
| Dec 31, 2025 | 496.71 Mn |
| Sep 30, 2025 | 139.82 Mn |
| Jun 30, 2025 | 33.47 Mn |
| Mar 31, 2025 | -22.69 Mn |
| Dec 31, 2024 | -513.70 Mn |
| Sep 30, 2024 | -146.14 Mn |
| Jun 30, 2024 | -68.67 Mn |
| Mar 31, 2024 | -10.61 Mn |
| Dec 31, 2023 | 17.21 Mn |
| Sep 30, 2023 | 508,744.00 |
| Jun 30, 2023 | 494,541.00 |
| Mar 31, 2023 | -746,421.00 |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | -351,016.00 |
| Jun 30, 2022 | -1.73 Mn |
| Mar 31, 2022 | -134,032.00 |
| Dec 31, 2021 | -2.71 Mn |
| Sep 30, 2021 | -152,249.00 |